Efficacy and safety of Exubera (inhaled insulin) compared with subcutaneous human insulin therapy in adult subjects with type 2 diabetes mellitus: a long-term, outpatient, open-label, parallel-group comparative trial.

Status: Discontinued

Phase of Trial: Phase III

Latest Information Update: 03 Oct 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Insulin (Primary) ; Insulin
Indications Type 2 diabetes mellitus
Focus Adverse reactions

Most Recent Events

21 Jul 2008 Status changed from recruiting to discontinued, as reported by ClinicalTrials.gov.
03 Jan 2008 The expected completion date for this trial is now 1 Mar 2010.
03 Jan 2008 Status change from in progress to recruiting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight